Benefits of combined hormonal contraceptives continue to outweigh risks
Product information to be updated to help women make informed decisions about their choice of contraception
26-Nov-2013 -
The European Medicines Agency has now completed its review of combined hormonal contraceptives (CHCs), particularly of the risk of venous thromboembolism (VTE or blood clots in veins) associated with their use. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) ...
contraception
myocardial infarction
stroke
+1